Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls

Pancreatic adenocarcinoma (PaC) is one of most difficult tumors to treat. Much of this is attributed to the late diagnosis. To identify biomarkers for early detection, we examined DNA methylation differences in leukocyte DNA between PaC cases and controls in a two-phase study. In phase I, we measure...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pedersen, Katrina S., Bamlet, William R., Oberg, Ann L., de Andrade, Mariza, Matsumoto, Martha E., Tang, Hui, Thibodeau, Stephen N., Petersen, Gloria M., Wang, Liang
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3063802/
https://ncbi.nlm.nih.gov/pubmed/21455317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0018223
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires